HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.107.042317v1 48/10/1633    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cosgrove, K. P. Articles by Staley, J. K. Search for Related Content PubMed PubMed Citation Articles by Cosgrove, K. P. Articles by Staley, J. K.

¹²³I-5-IA-85380 SPECT Imaging of Nicotinic Acetylcholine Receptor Availability in Nonsmokers: Effects of Sex and Menstrual Phase

¹ Yale University School of Medicine, New Haven, Connecticut; ² Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; ³ Institute for Neurodegenerative Disorders, New Haven, Connecticut; and ⁴ University of Minnesota, Minneapolis, Minnesota

Correspondence: For correspondence or reprints contact: Kelly P. Cosgrove, PhD, Yale University School of Medicine and the VACHS, Department of Psychiatry/116A6, 950 Campbell Ave., West Haven, CT 06516. E-mail: kelly.cosgrove{at}yale.edu

The study of the effects of sex and hormones on brain chemistry and neurotransmission is of increasing importance as evidence emerges of sex differences in behavioral symptoms and treatment response in neuropsychiatric disorders. The nicotinic acetylcholine receptor (nAChR) system has been implicated in a variety of psychiatric disorders, including tobacco smoking, for which there is strong evidence supporting sex differences in behaviors and response to smoking cessation treatments. We examined the availability of nAChR containing the ß₂ subunit in healthy men and women and the influence of menstrual phase among women. Methods: Ten men and 19 women nonsmokers underwent one ¹²³I-5-IA-85380 (¹²³I-5-IA) SPECT scan and one MRI scan. A subset of 9 women, aged 18–39 y, underwent a second ¹²³I-5-IA scan. These 9 women were scanned during the early follicular (days 4–7 in 8 subjects and day 11 in 1 subject) and mid-luteal (days 19–25) phases of their menstrual cycle. Hormone levels were measured in all women to confirm the phase of the cycle. Results: Regional brain activity (kBq/cm³) was higher (39%–54%) in women than in men nonsmokers. When regional brain activity was normalized to total plasma parent to correct for individual differences in radiotracer metabolism (V_T'), differences of 10%–16% were observed, with women greater than men. In contrast, when regional brain activity was normalized to free plasma parent (V_T), there was less than a 4% difference by sex in regional brain ß₂-nAChR availability. These sex differences in kBq/cm³ and V_T' resulted from significantly higher levels of total plasma parent, free fraction (f₁), and free plasma parent in women than in men nonsmokers. No differences in plasma measures or brain ß₂-nAChR availability were observed across the menstrual cycle for any outcome measure. Conclusion: Overall, these findings demonstrate no significant difference in brain ß₂-nAChR availability between men and women nonsmokers or across the menstrual cycle. Importantly, these findings demonstrate sex differences in radiotracer metabolism and plasma protein binding and highlight the critical need to measure plasma radiotracer levels and f₁ in studies that include both sexes.

Key Words: nicotinic • ¹²³I-5-IA-85380 • free fraction • sex • menstrual cycle • SPECT

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2007 48: 11A-12A. [Full Text]  

This article has been cited by other articles:

				T. B. Baker, K. M. Cummings, D. K. Hatsukami, C. A. Johnson, C. Lerman, R. Niaura, and S. S. O'Malley Transdisciplinary Tobacco Use Research Centers: Research achievements and future implications Nicotine Tob Res, October 1, 2009; 11(10): 1231 - 1244. [Full Text] [PDF]

				E. M. Mitsis, K. M. Reech, F. Bois, G. D. Tamagnan, M. G. MacAvoy, J. P. Seibyl, J. K. Staley, and C. H. van Dyck 123I-5-IA-85380 SPECT Imaging of Nicotinic Receptors in Alzheimer Disease and Mild Cognitive Impairment J. Nucl. Med., September 1, 2009; 50(9): 1455 - 1463. [Abstract] [Full Text] [PDF]

				P. M. Meyer, K. Strecker, K. Kendziorra, G. Becker, S. Hesse, D. Woelpl, A. Hensel, M. Patt, D. Sorger, F. Wegner, et al. Reduced {alpha}4{beta}2*-Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease Arch Gen Psychiatry, August 1, 2009; 66(8): 866 - 877. [Abstract] [Full Text] [PDF]